The effects of a prebiotic galactooligosaccharide mixture (B-GOS) on the severity of hyperpnea-induced bronchoconstriction and airway inflammation in adults with asthma

ottingham Trent University0 个研究点目标入组 24 人开始时间: 2016年1月6日最近更新: 2018年3月26日

适应症

试验速览

暂无简介。

•1. Body mass index (BMI) 20-25 KG.M-2
•2. Physically active 3 or more times a week , with each exercise session lasting at least 45 min
•3. Non-smoker
•4. Non-vegetarian or vegan
•5. Asthma sufferers must have own clinically prescribed medication
•6. Asthma sufferers must have a GP diagnosis

•1. Predicted forced expiratory volume in 1 second (FEV1) less than 65%
•2. Previously diagnosed with COPD, emphysema, chronic bronchitis or similar respiratory illness
•3. Previously admitted to hospital for asthma or other breathing difficulties
•4. Asthma exacerbation within the last month (Course of steroids, or hospital visit)
•5. History of heart failure, pulmonary hypertension, embolism, or other pulmonary heart disease
•6. History of recurrent chest infections
•8. Acute infection within the last four weeks
•9. Major operation within the past four months
•10. Have a history of taking ?-3 PUFA supplements or supplements with antioxidants above recommended intake, or consume more than three fatty fish meals per week
•11. Take a daily dose of aspirin or other NSAIDs
•12. Currently taking a daily dose of anti-histamine
•13. Currently taking long term asthma maintenance medications – corticosteroids, and leukotriene modifiers that you could not refrain from taking for 4 days prior to laboratory session

发起方

ottingham Trent University